Which returned more over the last year, EMB or XBI?

In the year to Sep 12, 2026, with distributions reinvested, EMB returned +2.8% and XBI returned +64.0%, so XBI returned more. One year is one year; the longer windows are in the table.

Which is cheaper, EMB or XBI?

EMB charges 0.39% a year and XBI charges 0.35%, so XBI is cheaper. Fees come from each fund's prospectus.

Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.

ETFIQetfiq.com · independent ETF data

EMB vs XBI: how they differ

EMB and XBI hold 0% of their weight in the same names, and XBI returned more over the year.

iShares J.P. Morgan USD Emerging Markets Bond ETF and State Street(R) SPDR(R) S&P(R) Biotech ETF.

What they hold in common

By the books each fund has filed, EMB and XBI hold 0% of their money in the same securities at the same weight.

Largest positions each one holds and the other does not
Only in EMB	Only in XBI
Argentina Republic Government Internatio 1.12%	Apogee Therapeutics Inc 1.49%
Argentina Republic Government Internatio 0.73%	Moderna Inc 1.41%
Argentina Republic Government Internatio 0.64%	Twist Bioscience Corp 1.41%
Argentina Republic Government Internatio 0.53%	Oruka Therapeutics Inc 1.38%
Uruguay Government International Bonds 0.52%	Kymera Therapeutics Inc 1.36%
EAGLE FUNDING LUXCO SARL 0.51%	Viking Therapeutics Inc 1.31%
Republic of Poland Government Internatio 0.40%	Praxis Precision Medicines Inc 1.29%
UKRAINE GOVERNMENT 0.38%	Erasca Inc 1.27%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.

EMB and XBI on the fields both publish, as of Sep 12, 2026. Source: ETFIQ.
	EMB iShares J.P. Morgan USD Emerging Markets Bond ETF	XBI State Street(R) SPDR(R) S&P(R) Biotech ETF
Where it sits	Core index fund	Core index fund
Issuer	iShares	State Street
What it is	J.P. Morgan USD Emerging Markets Bond	SPDR S&P Biotech
Total return, 1 year	+2.8%	+64.0%
S&P 500 over the same days	+17.5%	+17.5%
Gap to the S&P 500	−14.7 pts	+46.5 pts
Expense ratio	0.39%	0.35%
Holdings	681	150

EMB in plain words

EMB is a bond fund tracking the J.P. Morgan USD Emerging Markets Bond. Over the year to Sep 11, 2026 it returned +2.8% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.39% a year.

XBI in plain words

XBI is an index equity fund tracking the SPDR S&P Biotech. Over the year to Sep 11, 2026 it returned +64.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.35% a year. By its holdings filed for Jun 30, 2026, 8% of the fund by weight is stocks the S&P 500 also holds, across 150 positions, with the top ten at 13.3%. It sat 9.6% below its high of Feb 8, 2021 on Sep 11, 2026.

Questions people ask

Which returned more over the last year, EMB or XBI?: In the year to Sep 12, 2026, with distributions reinvested, EMB returned +2.8% and XBI returned +64.0%, so XBI returned more. One year is one year; the longer windows are in the table.
Which is cheaper, EMB or XBI?: EMB charges 0.39% a year and XBI charges 0.35%, so XBI is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where to next

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

EMB against XBI, ETFIQ, data as of Sep 12, 2026. Every figure is arithmetic on a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, EMB against XBI, data as of Sep 12, 2026. https://etfiq.com/compare/any/EMB-XBI Free to use with attribution; the underlying files are at Open data.

A comparison is not a recommendation. Standards and sources